HU191131B - Process for preparing 13-alpha-alkyl-gonanes and pharmaceutical compositions containing such compounds - Google Patents

Process for preparing 13-alpha-alkyl-gonanes and pharmaceutical compositions containing such compounds Download PDF

Info

Publication number
HU191131B
HU191131B HU842310A HU231084A HU191131B HU 191131 B HU191131 B HU 191131B HU 842310 A HU842310 A HU 842310A HU 231084 A HU231084 A HU 231084A HU 191131 B HU191131 B HU 191131B
Authority
HU
Hungary
Prior art keywords
methyl
hydroxy
formula
dimethylaminophenyl
compound
Prior art date
Application number
HU842310A
Other languages
English (en)
Hungarian (hu)
Other versions
HUT36139A (en
Inventor
Guenther Neep
Gerhard Sauer
Rudolf Wiechert
Sybilla Beier
Walter Elger
David Henderson
Ralph Rohde
Original Assignee
Schering Ag,De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3321826A external-priority patent/DE3321826A1/de
Priority claimed from DE19843413036 external-priority patent/DE3413036A1/de
Application filed by Schering Ag,De filed Critical Schering Ag,De
Publication of HUT36139A publication Critical patent/HUT36139A/hu
Publication of HU191131B publication Critical patent/HU191131B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU842310A 1983-06-15 1984-06-14 Process for preparing 13-alpha-alkyl-gonanes and pharmaceutical compositions containing such compounds HU191131B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3321826A DE3321826A1 (de) 1983-06-15 1983-06-15 13(alpha)-alkylgonane, deren herstellung und diese enthaltende pharmazeutische praeparate
DE19843413036 DE3413036A1 (de) 1984-04-04 1984-04-04 13(alpha)-alkylgonane, deren herstellung und diese enthaltende pharmazeutische praeparate

Publications (2)

Publication Number Publication Date
HUT36139A HUT36139A (en) 1985-08-28
HU191131B true HU191131B (en) 1987-01-28

Family

ID=25811539

Family Applications (1)

Application Number Title Priority Date Filing Date
HU842310A HU191131B (en) 1983-06-15 1984-06-14 Process for preparing 13-alpha-alkyl-gonanes and pharmaceutical compositions containing such compounds

Country Status (16)

Country Link
EP (1) EP0129499B1 (en, 2012)
JP (1) JPH02167296A (en, 2012)
AU (1) AU572849B2 (en, 2012)
CA (1) CA1307784C (en, 2012)
DD (1) DD218624A5 (en, 2012)
DE (1) DE3468030D1 (en, 2012)
DK (1) DK166729B1 (en, 2012)
ES (1) ES533260A0 (en, 2012)
FI (1) FI78709C (en, 2012)
GR (1) GR82210B (en, 2012)
HU (1) HU191131B (en, 2012)
IE (1) IE57620B1 (en, 2012)
IL (1) IL72085A (en, 2012)
NO (1) NO160521C (en, 2012)
NZ (1) NZ208441A (en, 2012)
PT (1) PT78732B (en, 2012)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3446661A1 (de) * 1984-12-18 1986-06-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 13(alpha)-alkyl-17(beta)-(3-acyloxypropyl)-gonane
DE3506785A1 (de) * 1985-02-22 1986-08-28 Schering AG, Berlin und Bergkamen, 1000 Berlin 11ss-n,n-dimethylaminophenyl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3630030A1 (de) * 1986-09-01 1988-03-03 Schering Ag 13(alpha)-alkylgonan-(delta)(pfeil hoch)9(pfeil hoch)(pfeil hoch)((pfeil hoch)(pfeil hoch)1(pfeil hoch)1(pfeil hoch))(pfeil hoch)-5,10-epoxide
US4774236A (en) * 1986-09-17 1988-09-27 Research Triangle Institute 17α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and pharmaceutical compositions containing them
IE60780B1 (en) * 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
EP0310542B1 (de) * 1987-10-01 1994-06-08 Schering Aktiengesellschaft Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren
BE1004905A4 (fr) * 1987-12-30 1993-02-23 Roussel Uclaf Nouveaux derives 17beta-oh 19-nor steroides substitues en 17alpha, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
US4954490A (en) * 1988-06-23 1990-09-04 Research Triangle Institute 11 β-substituted progesterone analogs
DE3822770A1 (de) * 1988-07-01 1990-01-04 Schering Ag 13-alkyl-11ss-phenylgonane
DE3832303A1 (de) * 1988-09-20 1990-04-12 Schering Ag 11ss-phenyl-14ssh-steroide
US5364847A (en) * 1989-03-10 1994-11-15 Endorecherche Inhibitors of sex steroid biosynthesis and methods for their production and use
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
DE69034035T2 (de) * 1989-07-07 2004-01-22 Endorecherche Inc., Ste-Foy Methode zur behandlung androgenbedingter krankheiten
WO1991000732A1 (en) * 1989-07-07 1991-01-24 Endorecherche Inc. Androgen derivatives for use in the inhibition of sex steroid activity
WO1991001958A2 (de) * 1989-08-04 1991-02-21 Schering Aktiengesellschaft Berlin Und Bergkamen 11β-ARYL-GONA-4,9-DIEN-3-ONE
FR2654337B1 (fr) * 1989-11-15 1994-08-05 Roussel Uclaf Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
DE4008584A1 (de) * 1990-03-15 1991-09-26 Schering Ag Verfahren zur herstellung von zwischenprodukten fuer die antigestagensynthese (onapristonsynthese)
US5407928A (en) * 1990-08-15 1995-04-18 Schering Aktiengesellschaft 11β-aryl-gona-4,9-dien-3-ones
ES2103818T3 (es) * 1990-08-18 1997-10-01 Schering Ag Procedimiento para la preparacion de 17-oxo-esteroides.
US5472854A (en) * 1990-08-18 1995-12-05 Schering Aktiengesellschaft Process for the production of 17-oxosteroids via the fermentative oxidation of 17β-hydroxysteroids by Mycobacterium
US7704983B1 (en) 1992-03-02 2010-04-27 Eastern Virginia Medical School Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception
MX9301121A (es) * 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
US5439913A (en) 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
FI945457A7 (fi) * 1992-05-21 1995-01-16 Endorecherche Inc Testosteronin 5alfa-reduktaasiaktiviteetin inhibiittorit
DE4413185A1 (de) * 1994-04-12 1995-10-19 Schering Ag 11beta,19-überbrückte 13alpha-Alkylsteroide
DE4415590A1 (de) * 1994-04-28 1995-11-02 Schering Ag Verfahren zur stereoselektiven Einführung einer Alkinylseitenkette an 11ß-Aryl-substituierten 13alpha-Alkylgonan-17-onen
DE4434488A1 (de) 1994-09-14 1996-03-21 Schering Ag Steroidester und -amide, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
ZA9510926B (en) 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
RU2129125C1 (ru) * 1995-04-06 1999-04-20 Украинский научно-исследовательский институт фармакотерапии эндокринных заболеваний СПОСОБ ПОЛУЧЕНИЯ 13α--1,3,510-ТРИЕН-19-НОРАНДРОСТАН-3-ОЛ-17-ОНА И ЕГО МЕТИЛОВОГО ЭФИРА
ES2152671T3 (es) 1996-05-01 2001-02-01 Us Gov Health & Human Serv Derivados de progesterona sustituidos en posicion 21 como nuevos agentes antiprogestacionales.
US6900193B1 (en) * 1996-05-01 2005-05-31 The United States Of America As Represented By The Department Of Health And Human Services Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
US6262042B1 (en) * 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
RU2017112748A (ru) 2014-11-17 2018-12-19 Арно Терапьютикс, Инк. Композиции онапристона пролонгированного действия и способы
AU2016326657B2 (en) * 2015-09-25 2019-10-24 Context Biopharma, Inc. Methods of making onapristone intermediates
HK1255104A1 (zh) 2015-12-15 2019-08-02 Context Biopharma Inc. 无定形的奥那司酮组合物及其制备方法
WO2018102369A1 (en) 2016-11-30 2018-06-07 Arno Therapeutics, Inc. Methods for onapristone synthesis dehydration and deprotection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2377418A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
DE3347126A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
CA1304916C (en) * 1984-10-18 1992-07-14 Wilhelm Bannwarth Apparatus for the parallel performance of a plurality of chemical reaction sequences

Also Published As

Publication number Publication date
HUT36139A (en) 1985-08-28
IL72085A (en) 1987-09-16
FI78709B (fi) 1989-05-31
GR82210B (en, 2012) 1984-12-13
NO842394L (no) 1984-12-17
EP0129499B1 (de) 1987-12-09
DK166729B1 (da) 1993-07-05
NO160521C (no) 1989-04-26
JPH0369919B2 (en, 2012) 1991-11-05
NO160521B (no) 1989-01-16
EP0129499A3 (en) 1985-10-09
AU572849B2 (en) 1988-05-19
EP0129499A2 (de) 1984-12-27
IE841484L (en) 1984-12-15
IE57620B1 (en) 1993-02-10
DK288184D0 (da) 1984-06-12
DD218624A5 (de) 1985-02-13
DK288184A (da) 1984-12-16
FI842395A7 (fi) 1984-12-16
JPH02167296A (ja) 1990-06-27
FI842395A0 (fi) 1984-06-13
IL72085A0 (en) 1984-10-31
DE3468030D1 (en) 1988-01-21
CA1307784C (en) 1992-09-22
ES8502612A1 (es) 1985-02-01
NZ208441A (en) 1988-01-08
FI78709C (fi) 1989-09-11
ES533260A0 (es) 1985-02-01
PT78732B (de) 1986-06-03
AU2936184A (en) 1984-12-20
PT78732A (pt) 1985-01-01

Similar Documents

Publication Publication Date Title
HU191131B (en) Process for preparing 13-alpha-alkyl-gonanes and pharmaceutical compositions containing such compounds
JP2664390B2 (ja) 新規な１１−アリールステロイド誘導体
JP2956776B2 (ja) １３―アルキル―１１β―フエニルゴナン
JPH01279897A (ja) 新規な１１β位置換ステロイド誘導体の製造中間体
US5272140A (en) 11-aryl steroid derivatives
JP3462515B2 (ja) １７−スピロフラン−３′−イリデンステロイド
HU191739B (en) Process for producing 11-beta-estradiene derivatives and pharmaceutical compositions containing them
FR2522328A1 (fr) Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
DK162101B (da) 11beta-(4-isopropenylphenyl)-oestra-4,9-diener, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse forbindelser samt anvendelsen af forbindelserne til fremstilling af laegemidler
US4292251A (en) 11β-Substituted steroids
HUP0700439A2 (en) Industrial method for the synthesis of 17-acetoxy-11betha-4[-(dimethylamino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione and the key intermediates of the process
JPH0216760B2 (en, 2012)
JP2003515543A (ja) １４，１５−ベータ−メチレン置換されたアンドロゲン
AU770331B2 (en) Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
DE3410880A1 (de) 17-substituierte estradiene und estratriene
JPH0649717B2 (ja) 二重結合又は三重結合を含む基で１０位置が置換された新規なステロイド、それらの製造法及び薬剤
CS203912B2 (en) Process for preparing derivatives of estradiene
FI102902B (fi) Menetelmä terapeuttisesti käyttökelpoisten 14 ,17 -silloitettujen es tratrieenien valmistamiseksi
JPS6210238B2 (en, 2012)
WO1993021204A1 (en) Method for preparing cholesta-5,7-diene-3-beta,25-diol and analogs thereof
Cross et al. Steroids CCLXXII (1). Biologically-active labile ethers III (2). A new class of potent estrogens
NO143065B (no) Kjemiske forbindelser for anvendelse i antikonsepsjonsmidler
DE3413036A1 (de) 13(alpha)-alkylgonane, deren herstellung und diese enthaltende pharmazeutische praeparate

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HMM4 Cancellation of final prot. due to non-payment of fee